Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo
Abstract Anti-HSV therapies are only suppressive because they do not eliminate latent HSV present in ganglionic neurons, the source of recurrent disease. We have developed a potentially curative approach against HSV infection, based on gene editing using HSV-specific meganucleases delivered by adeno...
Huvudupphovsmän: | , , , , , , , , , , |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Nature Portfolio
2024-05-01
|
Serie: | Nature Communications |
Länkar: | https://doi.org/10.1038/s41467-024-47940-y |